Welcome to the reserved area of SiderAL®

This section includes studies on iron deficiency and iron deficiency anaemia in patients undergoing bariatric surgery, with particular attention to the management of iron supplementation.

The studies in this section focus on improving haematological and functional parameters and postoperative outcomes in patients with various types of heart disease.

A collection of scientific evidence on iron deficiency in patients with gastrointestinal disorders, including inflammatory bowel disease (IBD) and coeliac disease.

The studies in this section investigate the efficacy of Sucrosomial^® Iron in the management of post-stroke fatigue and in improving motor and cognitive performance in older adults.

This section includes guidelines, literature reviews and consensus documents on the diagnosis and management of iron deficiency and anaemia across different clinical settings.

This section includes studies and research on the haemoglobin profile of pregnant women and the foetus. The studies describe the benefits of an optimal iron intake during pregnancy, such as optimal foetal birth weight.

This section includes studies demonstrating the high efficacy and excellent tolerability of Sucrosomial^® Iron compared with other oral iron salts in patients with iron deficiency anaemia caused by haematological disorders.

This section includes a collection of studies on various clinical conditions, such as multifactorial anaemia.

This section is dedicated to studies in patients with kidney disorders that cause alterations in key haematological parameters, as occurs in patients with chronic kidney disease (CKD).

The studies collected in this section focus on iron deficiency in the paediatric population, from the first year of life through adolescence.

This section includes studies and pharmacoeconomic analyses on the management of iron deficiency and anaemia, with particular attention to healthcare resource utilisation and associated costs.

This collection of in vivo and in vitro studies demonstrates the efficacy of Sucrosomial^® Iron in animal models, biological tissues and cell culture models.

The studies in this section focus on patients with cancer, with the primary aim of improving their haematological status and overall quality of life.

The studies in this section focus on iron deficiency in athletes and its impact on performance, with particular attention to the management of iron levels in sports and physical activity.

The studies in this section explore the management of iron deficiency before, during and after surgery, in accordance with the principles of Patient Blood Management (PBM).

The research collected in this section focuses on patients who have received or are candidates for blood transfusion and on the role of iron supplementation in the management of their haematological status.